Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs
Part of paid clinical trials in Totowa, New Jersey.
- Sponsor
- SpotitEarly
- Study ID
- NCT07038785
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Breath test — DIAGNOSTIC_TESTBreath sample collection using a sample collection kit
Study Details
The goal of this study is to find out whether a system that uses trained detection dogs and artificial intelligence (AI) can identify breast cancer from a person's breath. Women who are scheduled to have routine breast cancer screening, such as a mammogram, ultrasound, or a biopsy for a possible cancer, will be invited to take part. Participants will be asked to breathe into a surgical mask to collect a breath sample. The mask will be sent to a special laboratory, where trained dogs and an AI-based system will check the sample for signs of breast cancer. The results from the dogs and AI will be compared to the actual results from the medical screening or biopsy to see how accurate the system is at detecting breast cancer.
Key Dates
- Start date
- Jul 22, 2025
- Status verified
- Aug 2025
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 1,204 participants (estimated)
Arms
- Arm: Target Population ArmWomen scheduled for routine breast cancer screening by mammography/ultrasound/magnetic resonance imaging
- Arm: Enriched ArmWomen scheduled for breast biopsy with a Breast Imaging and Reporting Data System (BI-RADS®) score of 4B or above
Primary Outcome Measure
Test Performance Evaluation [ Time Frame: 24 months ]
Central Contacts
- Udi Bobrovsky+972-54-456-0008
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hackensack Meridian Health | Totowa | New Jersey | 07512 | Elias Obeid, MD, MPH (PRINCIPAL_INVESTIGATOR) |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Brian S Englander, MD (PRINCIPAL_INVESTIGATOR) Elizabeth McDonald, MD, PhD (SUB_INVESTIGATOR) |
Find similar trials in Totowa, NJ
Related Studies
- Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA MutationsRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and SerumRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Cardiotoxicity of Cancer Therapy (CCT)Enrolling By Invitation · Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania